BioLife Solutions Announces First Quarter 2021 Financial Results Achieves record quarterly revenue of $16.8 million, a 39% increase over the prior year and 14% increase over the prior quarter Full year revenue guidance raised to $106 to $115 million reflecting confidence in outlook Additions to leadership team and board position company for continued robust growth serving the cell and gene therapy and biopharma markets Conference call begins at 4:30 p.m. Eastern time today News provided by Share this article , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier...